Cases 41 - 50 of 344
Amgen Inc. et al v. USV Private Limited
as 1:2022cv00387
Counter Defendant:
Amgen Inc. and KAI Pharmaceuticals, Inc.
Counter Claimant:
USV Private Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
UFCW Local 1500 Welfare Fund, et al v. AbbVie Inc., et al
as 20-2402
Defendant / Appellee:
MYLAN INC., MYLAN PHARMACEUTICALS, INC., SAMSUNG BIOEPIS CO. LTD. and others
Plaintiff / Appellant:
UFCW LOCAL 1500 WELFARE FUND, on behalf of itself and all others similarly situated, LOUISIANA HEALTH SERVICE & INDEMNITY COMPANY, doing business as BLUE CROSS BLUE SHIELD OF LOUISIANA, LOCALS 302 & 612 OF THE INTERNATIONAL UNION OF OPERATING ENGINEERS- EMPLOYERS CONSTRUCTION INDUSTRY HEALTH AND SECURITY TRUST FUND and others
Amicus Curiae:
66 LAW, ECONOMICS, BUSINESS, AND MEDICAL PROFESSORS, NATIONAL ASSOCIATION OF CHAIN DRUG STORES, INCORPORATED, CONSUMER ACTION AND U.S. PUBLIC INTEREST RESEARCH GROUP and others
Amgen Inc. et al v. Aurobindo Pharma Limited et al
as 1:2022cv00227
Plaintiff:
Amgen Inc. and KAI Pharmaceuticals, Inc.
Defendant:
Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., Eugia Pharma Specialties Limited and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
United States of America, ex r v. Amgen Inc.
as 22-18
Plaintiff:
United States of America, Ex Rel. Joseph Piacentile and Kevin B. Kilcoyne, State of California, State of Delaware and others
Petitioner / Appellant:
Joseph Piacentile and Kevin Kilcoyne
Defendant / Appellee:
U.S. Oncology, Inc.
Defendant:
Amgen, Inc., Amerisource Bergen Corp., Amerisource Bergen Specialty Group, Inc. and others
Amgen Inc. v. Aurobindo Pharma Limited et al
as 1:2022cv00037
Plaintiff:
Amgen Inc. and KAI Pharmaceuticals, Inc.
Defendant:
Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., Eugia Pharma Specialties Limited and others
Cause Of Action: 35 U.S.C. § 271
Lindis Biotech, GmbH v. Amgen Inc.
as 1:2022cv00035
Plaintiff:
Lindis Biotech, GmbH
Defendant:
Amgen Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In Re: Humira (Adalimumab) Antitrust Litigation
as 1:2019cv01873
Defendant:
MYLAN PHARMACEUTICALS, INC., SANDOZ, INC., MOMENTA PHARMACEUTICALS, INC. and others
Plaintiff:
UFCW LOCAL 1500 WELFARE FUND, Plaintiffs, Locals 302 & 612 of the International Union of Operating Engineers-Employers Construction Industry Health and Security Trust Fund and others
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation
Amgen Inc. v. Sandoz Inc.
as 22-1147
Cross Appellant:
AMGEN INC.
Defendant / Appellee:
MANKIND PHARMA LTD., TORRENT PHARMACEUTICALS LTD., GLENMARK PHARMACEUTICALS LIMITED and others
Defendant / Appellant:
ZYDUS PHARMACEUTICALS (USA) INC. and SANDOZ INC.
Amgen Inc. v. Sandoz Inc.
as 22-1149
Plaintiff / Appellant:
AMGEN INC.
Defendant / Appellee:
SANDOZ INC., MANKIND PHARMA LTD., TORRENT PHARMACEUTICALS LTD. and others
Amgen Inc. v. Sandoz Inc.
as 22-1150
Cross Appellant:
AMGEN INC.
Defendant / Appellant:
SANDOZ INC.
Defendant / Appellee:
MANKIND PHARMA LTD., TORRENT PHARMACEUTICALS LTD., GLENMARK PHARMACEUTICALS LIMITED and others
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
